HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.

Abstract
We previously reported a monoclonal antibody named IF-43 that specifically recognizes thrombin-modified fibrinogen (desAA- and desAABB- fibrin monomer) bound with fibrinogen or other D(1) domain-containing plasmic fragments such as fragments X,Y, and D(1), but not intact fibrinogen or cross-linked fibrin degradation products (XDP). Here, we tentatively named such complexes, soluble fibrin monomer (FM) -fibrinogen complex. By utilizing IF-43, we have developed a kit to measure soluble FM-fibrinogen complex and compared the profiles with those of two established molecular markers for thrombo-embolic disorders: i.e. the thrombin-antithrombin complex (TAT) and the D-dimer in plasma of patients who underwent surgery without any thrombo-embolic complications. The result indicated that soluble FM-fibrinogen complex is a distinct entity from the two established molecular markers. We have also attempted to observe their profiles in patients with the disseminated intravascular coagulation syndrome (DIC). Although the pro-files of soluble FM-fibrinogen complex in individual patients appeared to vary from one patient to the other, the plasma level of soluble FM-fibrinogen complex was found to be increased at the initial phase of disseminated intravascular coagulation syndrome. Thus, the soluble FM-fibrinogen complex may serve as an independent molecular marker for the detection of thrombin generation and the diagnosis of thrombosis. The soluble FM-fibrinogen complex may also serve as a risk factor for thrombosis, because it may precipitate as insoluble complexes beyond its threshold in plasma, or when it is modified by thrombin.
AuthorsKunihiko Nakahara, Yumiko Kazahaya, Yuichi Shintani, Kensuke Yamazumi, Yutaka Eguchi, Shin Koga, Hideo Wada, Michio Matsuda
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 89 Issue 5 Pg. 832-6 (May 2003) ISSN: 0340-6245 [Print] Germany
PMID12719780 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • antithrombin III-protease complex
  • fibrin fragment D
  • Antithrombin III
  • Fibrin
  • Fibrinogen
  • Peptide Hydrolases
Topics
  • Antithrombin III
  • Biomarkers (blood)
  • Disseminated Intravascular Coagulation (blood)
  • Fibrin (analysis, metabolism)
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Fibrinogen (analysis, metabolism)
  • Humans
  • Latex Fixation Tests
  • Peptide Hydrolases (blood)
  • Plasma (chemistry)
  • Protein Binding
  • Risk Factors
  • Solubility
  • Thrombosis (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: